Search clinical trials for: biodegradable polymer

Total 1820 results

Konstantinos Toutouzas
Université Catholique de Louvain; University of Patras; Centre Hospitalier Universitaire... and other collaborators

Not yet recruiting

3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS

Coronary Artery Disease | Acute Coronary Syndrome

Belgium, Switzerland, Greece
Genoss Co., Ltd.

Recruiting

Evaluation of Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENCOMX)

Coronary Artery Disease | Percutaneous Coronary Intervention

Korea, Republic of
Shenzhen Zhongke Jingcheng Medical Technology Co...
Chinese University of Hong Kong; Shenzhen Institute of Advanced Technology,...

Recruiting

Mg-containing Biodegradable Polymer Bone Repair Material

Bone Deformity

China
Xijing Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Tang-Du Hospital; General... and other collaborators

Recruiting

HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population

Coronary Artery Disease

China
Sahajanand Medical Technologies Limited

Recruiting

S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

Coronary Artery Disease

Netherlands
Federico II University
AdvicePharma Group

Active, not recruiting

Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES (PARTHENOPE)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Chronic Coronary Syndrome

Italy
University of Zurich

Completed

MULTivessel Immediate Versus STAged RevaScularization in Acute Myocardial Infarction -The MULTISTARS AMI Trial (MULTISTARS AMI)

ST-elevation Myocardial Infarction | Multivessel Coronary Disease

Switzerland
Sahajanand Medical Technologies Limited
Cardiovascular European Research Center (CERC)

Completed

Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent

Coronary Artery Disease

Switzerland, Germany, France
JW Medical Systems Ltd

Completed

EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III) (CREDIT-III)

Coronary Artery Disease

China
Tomsk National Research Medical Center of the Russian...

Completed

Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent Implantation (Healing)

Coronary Heart Disease | Stable Angina Pectoris | Silent Myocardial Ischemia

Russian Federation
Foundation of Cardiovascular Research and Education...

Completed

Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT) (BIO-RESORT)

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris | Acute Coronary Syndrome | Angina, Unstable | Coronary Stenosis | Coronary Restenosis

Netherlands
Tokorozawa Heart Center
University Hospital Inselspital, Berne

Active, not recruiting

A Randomized Comparison of Long-Term Healing Between Biodegradable- Versus Durable-Polymer Everolimus Eluting Stents in STEMI (CONNECT)

STEMI - ST Elevation Myocardial Infarction

Japan
University Hospital Inselspital, Berne
University of Lausanne Hospitals

Completed

A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (BIOSTEMI)

Coronary Artery Disease | Acute Coronary Syndrome

Switzerland
Sino Medical Sciences Technology Inc.

Completed

First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis

Coronary Artery Disease

Netherlands, Belgium, Spain, Portugal
Iwate Medical University

Unknown

Comparison of MECHANISM of Early and Late Vascular Responses Following Treatment of ST-elevation Acute Myocardial Infarction With Two Different Everolimus-eluting Stents: Randomized Controlled Trial Between Biodegradable Polymer and Durable Polymer Stent (MECHANISM-AMI-RCT)

Coronary Artery Disease

Japan
Ospedale Santa Maria Goretti

Withdrawn

Optical Coherence Tomography Evaluation of a Biodegradable Polymer-based Drug-eluting Stent (PONTINA)

Coronary Artery Disease

Italy
Seoul National University Hospital
Boston Scientific Korea Co. Ltd; Dio; Terumo Corporation; Abbott

Unknown

Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

Acute Coronary Syndrome

Korea, Republic of
Shanghai MicroPort Medical (Group) Co., Ltd.

Completed

Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)

Coronary Artery Disease

China
Fundacion Investigacion Interhospitalaria Cardiovascular
B.Braun Surgical SA

Completed

Vessel Injury in Relation With Strut Thickness Assessed by OCT (VISTA)

Coronary Artery Disease

Spain
Hospital Universitari Vall d'Hebron Research Institute
B.Braun Surgical SA

Completed

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

Coronary Artery Disease

Spain
University Hospital Inselspital, Berne
University of Bern; Biotronik AG

Completed

Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents

Myocardial Infarction | Coronary Artery Disease | Angina Pectoris

Switzerland
Liuhuaqiao Hospital

Completed

Angiographic and IVUS Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

Percutaneous Coronary Angioplasty

China
Centre Hospitalier Universitaire de Besancon
University of Franche-Comté

Terminated

Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis (MicroIskin)

Atopic Dermatitis

France
Boston Scientific Corporation

Completed

Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent (Evolve)

Coronary Artery Disease

Spain, Belgium, France, Australia, United Kingdom, Sweden, New Zealand, Denmark, Poland
General Hospital of Chinese Armed Police Forces

Completed

Effect of TCFA on Neointimal Coverage After PCI at 9 Months Follow-up

Unrecognized Condition

China
University of Roma La Sapienza

Completed

Comparison of Biodegradable Polymer vs Durable-polymer in Diabetic Patients (RUDI 2D)

Diabetes Mellitus | Percutaneous Coronary Intervention
Yonsei University

Completed

Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents

Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension

Korea, Republic of
Sino Medical Sciences Technology Inc.

Completed

Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in "Real-World" Practice (PANDA-III)

Coronary Artery Disease

China
Chonnam National University Hospital

Unknown

Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome (BEAUTY-II)

Myocardial Infarction | Hemorrhage | Cerebrovascular Accident | Cardiac Death

Korea, Republic of
University Hospital, Basel, Switzerland

Completed

Safety and Efficacy Study Comparing 3 New Types of Coronary Stents

Coronary Artery Disease | Coronary Thrombosis

Denmark, Austria, Germany, Switzerland
Ajou University School of Medicine

Unknown

Comparison of Biolimus-eluting Biodegradable Polymer, Everolimus-eluting and Sirolimus-eluting Coronary Stents (BESS)

Coronary Artery Disease

Korea, Republic of
University of Roma La Sapienza

Unknown

Effects of a rapamycIn-eluting carboNized Stent With a Completely biodEgradable polymeR Coating (INERT)

Coronary Artery Disease
Kinhely Bio-tech Co., Ltd.
Peking University; RenJi Hospital

Unknown

A Prospective Multicenter Trial Evaluating Helios Biodegradable Polymer SES Safety and Effectiveness in CAD Treatment (Pro-HOPE)

Coronary Artery Disease

China
Deutsches Herzzentrum Muenchen

Unknown

Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents (ISAR-TEST6)

Coronary Heart Disease

Germany
Deutsches Herzzentrum Muenchen

Completed

Test Safety of Biodegradable and Permanent Limus-Eluting Stents Assessed by Optical Coherence Tomography (TEST-6-OCT)

Coronary Heart Disease

Germany
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions (ISAR-CABG)

Arteriosclerosis of Arterial Coronary Artery Bypass Graft

Germany
Centro de estudios en Cardiologia Intervencionista
Eucatech AG

Completed

A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent (EUCATAX)

Coronary Artery Disease

Argentina
Deutsches Herzzentrum Muenchen

Completed

3 Limus Agent Eluting Stents With Different Polymer Coating (ISAR-TEST-4)

Coronary Heart Disease

Germany
Chinese PLA General Hospital

Unknown

Optical Coherence TomOgraphy Assessment of the Drug-Eluting Stent (OCTOBER)

Atherosclerosis
JW Medical Systems Ltd

Unknown

A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions (EVOLUTION)

Myocardial Infarction | Ischemia | Cardiac Death

China
JW Medical Systems Ltd

Completed

Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent (CREATE)

AMI
Deutsches Herzzentrum Muenchen

Completed

Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)

Coronary Heart Disease

Germany
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Not yet recruiting

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

Ovarian Cancer

United States, Germany
Translumina GmbH
EVAMED

Recruiting

MULTICENTER OBSERVATORY EVALUATING THE POLYMER-FREE SIROLIMUS ELUTING CORONARY STENT SYSTEM VIVO ISAR IN ROUTINE CLINICAL PRACTICE (CELEBRITY)

Artery Coronary Stenosis

France
University of Cologne
AstraZeneca

Not yet recruiting

Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC) (GUIDANCE)

Small Cell Lung Carcinoma
University of Miami
GlaxoSmithKline

Not yet recruiting

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

Ovarian Cancer

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer

Endometrial Carcinoma | Recurrent or Metastatic | TP53 Mutation

China
University of Wisconsin, Madison
Merck Sharp & Dohme LLC

Not yet recruiting

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Kidney Transplant Infection | Cytomegalovirus Infections | Pancreas Transplant

United States
Qian Qin
Janssen, LP; UT Southwestern Comprehensive Cancer Center

Not yet recruiting

Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations (HARMONY)

BRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
Ivy Brain Tumor Center
GlaxoSmithKline

Not yet recruiting

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

Glioblastoma | Brain Tumor | GBM | Brain Neoplasms, Adult, Malignant

Search clinical trials for: biodegradable polymer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations